Singapore markets closed

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.08+0.19 (+0.96%)
At close: 04:00PM EDT
20.08 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7798
Avg. Estimate-0.95-0.97-3.89-4.32
Low estimate-1.15-1.2-5.1-5.4
High estimate-0.64-0.78-2.89-3.36
Year ago EPS-0.55-0.6-2.89-3.89
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4465
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.67-0.63-0.68-0.86
Actual EPS-0.55-0.6-0.71-0.99
Difference0.120.03-0.03-0.13
Surprise %17.90%4.80%-4.40%-15.10%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.95-0.97-3.89-4.32
7 days ago-0.95-0.97-3.89-4.32
30 days ago-1-1-3.97-4.33
60 days ago-0.9-0.93-3.58-4.28
90 days ago-0.91-0.95-3.54-4.23
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKROIndustrySector(s)S&P 500
Current qtr.-72.70%N/AN/AN/A
Next qtr.-61.70%N/AN/AN/A
Current year-34.60%N/AN/AN/A
Next year-11.10%N/AN/AN/A
Next 5 years (per annum)-14.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A